On February 6, 2026, Doximity, Inc. (NASDAQ: DOCS) was downgraded to a neutral rating by JP Morgan’s Alexei Gogolev, raising eyebrows among investors. The new price target of $40 suggests an upside potential from the stock’s current price of $33.32; however, this downgrade comes amidst a sustained decline in the stock over the past months, indicating broader concerns about the company’s trajectory.
Recent Price Action
Doximity’s share price has been under considerable pressure recently, dropping by approximately 23.25%. The stock closed at $33.32, substantially below its 52-week high of $85.67, reflecting a staggering decline of nearly 60.9%. The volatility around this stock has been pronounced, as exhibited by a weekly volatility rate of 4.35% and a monthly volatility rate of 3.55%. In the wake of this sell-off, trading volume surged significantly to 11,279,724 shares, dwarfing the average volume of 2,952,244 shares. This increased trading activity suggests a strong investor reaction that merits closer examination of market sentiment towards Doximity.
[chart type=’price’ value=’DOCS’]
Short- and Long-Term Performance
Examining Doximity’s performance over various time frames reveals a troubling trend. Over the past 30 days, the stock has declined by 5.97%, and quarterly performance reflects a more severe downturn of 39.17%. Year-over-year, Doximity has generated a negative return of 22.76%, which aligns with broader market conditions that have experienced volatility in tech stocks. This underperformance starkly contrasts its beta of 1.385, indicating higher volatility relative to the market. In the context of investor risk appetite, these figures may discourage potential investors seeking stability.
[chart type=’performance’ value=’DOCS’]
Earnings Analysis
In its latest earnings report as of November 6, 2025, Doximity saw its earnings per share (EPS) come in at $0.45, surpassing analysts’ expectations of $0.38 by a surprising 18.42%. This follows a prior EPS of $0.36, which itself exceeded estimates in the previous quarter, indicating a pattern of better-than-expected earnings. However, despite this positive earnings surprise, the stock’s persistent decline raises questions about the sustainability of these results and whether they can translate into long-term growth.
[chart type=’income-bar-chart’ value=’DOCS’]
Analyst / Consensus View
Consensus ratings for Doximity reveal a predominantly bullish outlook, with a total of 14 ratings reflecting 11 buys, three holds, and no sells. The average price target of $54.43 stands in stark contrast to Gogolev’s neutral rating, but the high target of $75 paints a picture of significant upside potential. However, the low target of $37 indicates that analysts are also bracing for further downside. This mixed sentiment serves as a cautionary note for investors weighing Doximity’s future prospects.
[chart type=’analyst-ratings’ value=’DOCS’]
Stock Grading or Fundamental View
The Stocks Telegraph Grade for Doximity is currently set at 57, indicating a moderate investment profile based on its underlying financial metrics and market performance. Generating a score within this range suggests that while Doximity possesses certain strengths, it may also encounter challenges that could affect its relative position in the market.
[chart type=’st-cards’ value=’DOCS’]
Conclusion
Doximity, Inc. may appeal to investors with a moderate risk appetite who are looking for potential upside amid recent volatility and earnings outperformance. However, the downgrade to neutral and erratic trading behavior warrant cautious consideration. Long-term growth investors should remain vigilant of market trends and the company’s ability to overcome the current bearish sentiment. At the same time, it’s crucial to recognize the inherent risks associated with investing in a company grappling with significant stock price fluctuations and investor skepticism. As the situation evolves, Doximity will be worth monitoring for signs of recovery or continued challenges.